Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In the 1 mg Phase 2 arm, participants lost about 8% of body weight over 48 weeks
Fat Loss Patterns Men lose proportionally more visceral fat (around internal organs), while women lose proportionally more subcutaneous fat (under the skin)
Key findings from OASIS 4 Double-blind, placebo-controlled, 64-week, phase 3 trial (N=307) Mean weight loss: 13.6% (semaglutide) vs 2.2% (placebo) 5% weight loss in 79.2% (semaglutide) vs 31.1% (placebo) Improvements in physical functioning and cardiometabolic markers Serious adverse events were lower in the semaglutide group (3.9% vs 8.8%) This could be a key player particularly among patients who are needle-averse, travel often, or seek simpler dosing options
human evidence for the blend is absent and individual results vary
Yes, if needed you can skip a week of Wegovy
Keep in mind that injections may qualify for manufacturer coupons or patient assistance programs, which can significantly lower out-of-pocket spending
US$ 23.76
US$ 25.63
US$ 28.87
US$ 22.31
